These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 27810279)

  • 1. Synthesis and characterisation of magnetised Dacron-heparin composite employed for antithrombin affinity purification.
    Mercês AA; Silva RS; Silva KJ; Maciel JD; Oliveira GB; Buitrago DM; de Aguiar JA; de Carvalho-Júnior LB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():73-79. PubMed ID: 27810279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of blood plasma proteins using heparin-coated magnetic chitosan particles.
    Merces AADD; Ferreira RDS; Silva KJS; Salu BR; Maciel JDC; Aguiar JAO; Tashima AK; Oliva MLV; Carvalho Júnior LB
    Carbohydr Polym; 2020 Nov; 247():116671. PubMed ID: 32829799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
    Krulder JW; Strebus AF; Meinders AE; Briët E
    Haemostasis; 1996; 26(2):85-9. PubMed ID: 9119287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of latent, prelatent, and native forms of human antithrombin by heparin affinity high-performance liquid chromatography.
    Karlsson G; Winge S
    Protein Expr Purif; 2004 Feb; 33(2):339-45. PubMed ID: 14711523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of canine antithrombin III-heparin cofactor using affinity chromatography.
    Damus PS; Wallace GA
    Biochem Biophys Res Commun; 1974 Dec; 61(4):1147-53. PubMed ID: 4141897
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation of antithrombin III from normal and alpha1-antitrypsin-deficient human plasma.
    Borsodi AD; Bradshaw RA
    Thromb Haemost; 1977 Aug; 38(2):475-85. PubMed ID: 304258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three novel high performance affinity chromatographic media for the separation of antithrombin III from human plasma.
    Zhao Y; Zhao R; Shangguan D; Xiong S; Liu G
    Biomed Chromatogr; 2001 Dec; 15(8):487-92. PubMed ID: 11748680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of plasma proteins from the clotting cascade by heparin affinity chromatography.
    Josić D; Bal F; Schwinn H
    J Chromatogr; 1993 Feb; 632(1-2):1-10. PubMed ID: 8454710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pasteurization of antithrombin without generation of the prelatent form of antithrombin.
    Karlsson G
    Protein Expr Purif; 2004 Jun; 35(2):381-6. PubMed ID: 15135417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: Affinity of antithrombin II/III to insolubilized heparin.
    Thaler E; Schmer G
    Thromb Diath Haemorrh; 1975 Sep; 34(1):346. PubMed ID: 1188789
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electrophoretic mobility of antithrombin III in an agarose gel with heparin. (author's transl)].
    Aiach M; Fiessinger JN; Andreux JP; Beuvin J; Housset E; Leclerc M
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():35-41. PubMed ID: 353657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of Bothrops jararaca snake antithrombin from the supernatant of fibrinogen purification.
    Morais-Zani K; Tanaka AS; Tanaka-Azevedo AM
    J Biomol Tech; 2009 Dec; 20(5):249-52. PubMed ID: 19949696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The different forms of antithrombin II in serum.
    Pepper DS; Banhegyi D; Cash JD
    Thromb Haemost; 1977 Aug; 38(2):494-503. PubMed ID: 579491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphotungstate as a useful eluent for antithrombin III purification by heparin-agarose affinity chromatography.
    Tajima Y; Shizuka R; Oshitani S; Amagai H
    Thromb Res; 1990 Mar; 57(5):697-704. PubMed ID: 2339364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An improved method for removal of antithrombin III from post-heparin plasma lipase fractions with a high recovery rate.
    Moriguchi EH; Tamachi H; Homma Y; Goto Y
    Tokai J Exp Clin Med; 1991 Mar; 16(1):33-41. PubMed ID: 1780907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico discovery of a compound with nanomolar affinity to antithrombin causing partial activation and increased heparin affinity.
    Navarro-Fernández J; Pérez-Sánchez H; Martínez-Martínez I; Meliciani I; Guerrero JA; Vicente V; Corral J; Wenzel W
    J Med Chem; 2012 Jul; 55(14):6403-12. PubMed ID: 22742452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of contact activation on end-point immobilized heparin: the role of antithrombin and the specific antithrombin-binding sequence.
    Sanchez J; Elgue G; Riesenfeld J; Olsson P
    J Biomed Mater Res; 1995 May; 29(5):655-61. PubMed ID: 7622551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography.
    Segura MM; Kamen A; Trudel P; Garnier A
    Biotechnol Bioeng; 2005 May; 90(4):391-404. PubMed ID: 15812800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of recombinant human antithrombin isoforms by Cellufine Sulfate affinity chromatography.
    Sugihara T; Fujiwara S; Ishioka S; Urakubo T; Suzawa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1095():198-203. PubMed ID: 30077924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.